| Meredith Brown, PHARM D | |
|
400 Oxford Exchange Blvd, Oxford, AL 36203-3459 | |
| (256) 231-2901 | |
| (256) 231-2911 |
| Full Name | Meredith Brown |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 400 Oxford Exchange Blvd, Oxford, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447545744 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14435 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Meredith Brown, PHARM D 400 Oxford Exchange Blvd, Oxford, AL 36203-3459 Ph: () - | Meredith Brown, PHARM D 400 Oxford Exchange Blvd, Oxford, AL 36203-3459 Ph: (256) 231-2901 |
News Archive
Cannabis Science Inc. a pioneering US biotech company developing pharmaceutical cannabis products, announces that on August 18, 2010, Cannabis Science signed with RockBrook Inc., its first manufacturing and development license for the Cannabis Science Brand of Pharmaceutical Products for the State of Colorado.
The 20th International Symposium on Human Identification will highlight advances in DNA technology and explore controversial issues brought about by the expanded power and use of DNA typing.
In findings that contradict previous studies, psychologists found that autistic children can 'read' a stranger's mental state based on that person's eyes. Autistic children have long been thought to be poor at interpreting people's mental states based on facial expressions, especially expressions around the eyes.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
Exhaust fumes heighten the risk of asthma in children who are already genetically susceptible to respiratory disease, indicates research published ahead of print in the journal Thorax.
› Verified 9 days ago
Nick Barrentine, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 Quintard Dr, Oxford, AL 36203 Phone: 256-831-6116 | |
Dr. Kai Martin, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 Quintard Dr, Oxford, AL 36203 Phone: 256-831-6116 | |
Roy Hall, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Snow St, Oxford, AL 36203 Phone: 256-831-7534 Fax: 256-831-4461 | |
Dr. Jeremy Arnold, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 Commons Way, Oxford, AL 36203 Phone: 256-835-4080 | |
Tom Hodges, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 92 Plaza Ln, Oxford, AL 36203 Phone: 256-835-0334 | |
Dennis E Wright, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Snow St, Oxford, AL 36203 Phone: 256-831-7535 Fax: 256-831-4461 | |
Mr. Richard Leslie Samples, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4880 Us Highway 78 W, Oxford, AL 36203 Phone: 256-831-7726 Fax: 256-835-8123 |